Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Immunol. Jul 27, 2014; 4(2): 63-77
Published online Jul 27, 2014. doi: 10.5411/wji.v4.i2.63
Figure 3
Figure 3 The potential effects of cytolytic T lymphocyte-associated antigen-4Ig treatment given after T cell priming. If cytolytic T lymphocyte antigen (CTLA)-4Ig is applied after priming when T cells are already activated, it mainly interferes with the CTLA-4/B7 interaction. This interaction is important for cell-intrinsic down-regulation of Teff cells. In the absence of this cell-intrinsic regulation, activated Teff cells proliferate more strongly and secrete more inflammatory cytokines. Furthermore, Treg cells are not able to exert their suppressive function mediated via CTLA-4. Both effects will potentially result in further increase of the T cell mediated inflammation. APC: Antigen presenting cell; Teff: Effector T cell; Treg: Regulatory T cell.